dr. black discusses the impact of durvalumab in bladder cancer
Published 7 years ago • 42 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:00
dr. black on combinations with durvalumab in bladder cancer
-
1:10
dr. powles discusses the future of durvalumab in bladder cancer
-
1:07
dr. balar on impact of durvalumab plus tremelimumab in bladder cancer
-
0:53
dr. black on the developments in the field of immunotherapy for bladder cancer
-
1:24
dr. black discusses immunotherapy biomarkers in bladder cancer
-
0:57
dr. black on sequencing of immunotherapy in bladder cancer
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
2:03
durvalumab fda approval for bladder cancer
-
1:43
dr. sonpavde discusses a study of fixed-dose durvalumab and tremelimumab in urothelial carcinoma
-
2:36
dr. joshi discusses durvalumab and radiation therapy in bladder cancer
-
1:05
dr. sonpavde on the role of durvalumab in platinum-refractory bladder cancer
-
1:33
dr. balar on results of durvalumab plus tremelimumab in bladder cancer
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
2:10
dr. langer on the benefit of durvalumab in stage iii nsclc
-
1:06
the mechanism of action of durvalumab in the treatment of urothelial bladder cancer
-
1:00
trial of durvalumab for bladder cancer
-
6:06
stage iii nsclc: when to start durvalumab
-
6:50
implications for using durvalumab in stage 3 nsclc
-
1:30
dr. spigel on the rationale behind the pacific trial